- Home
- BARK vs NPCE Comparison
BARK vs NPCE Comparison
Compare BARK & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- NPCE
- Stock Information
- Founded
- BARK 2011
- NPCE 1997
- Country
- BARK United States
- NPCE United States
- Employees
- BARK N/A
- NPCE N/A
- Industry
- BARK Department/Specialty Retail Stores
- NPCE Medical Specialities
- Sector
- BARK Consumer Discretionary
- NPCE Health Care
- Exchange
- BARK Nasdaq
- NPCE Nasdaq
- Market Cap
- BARK 308.9M
- NPCE 318.5M
- IPO Year
- BARK N/A
- NPCE 2021
- Fundamental
- Price
- BARK $1.89
- NPCE $11.58
- Analyst Decision
- BARK Buy
- NPCE Buy
- Analyst Count
- BARK 2
- NPCE 6
- Target Price
- BARK $2.20
- NPCE $15.83
- AVG Volume (30 Days)
- BARK 1.1M
- NPCE 66.9K
- Earning Date
- BARK 02-05-2025
- NPCE 11-12-2024
- Dividend Yield
- BARK N/A
- NPCE N/A
- EPS Growth
- BARK N/A
- NPCE N/A
- EPS
- BARK N/A
- NPCE N/A
- Revenue
- BARK $488,881,000.00
- NPCE $76,452,000.00
- Revenue This Year
- BARK $3.23
- NPCE $23.46
- Revenue Next Year
- BARK $10.01
- NPCE $15.49
- P/E Ratio
- BARK N/A
- NPCE N/A
- Revenue Growth
- BARK N/A
- NPCE 27.00
- 52 Week Low
- BARK $0.74
- NPCE $5.45
- 52 Week High
- BARK $2.56
- NPCE $18.15
- Technical
- Relative Strength Index (RSI)
- BARK 45.84
- NPCE 59.49
- Support Level
- BARK $1.81
- NPCE $10.43
- Resistance Level
- BARK $1.94
- NPCE $11.62
- Average True Range (ATR)
- BARK 0.12
- NPCE 0.95
- MACD
- BARK -0.05
- NPCE -0.12
- Stochastic Oscillator
- BARK 15.69
- NPCE 66.67
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.